Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-15-000841
Filing Date
2015-11-19
Accepted
2015-11-18 20:53:07
Documents
2
Group Members
ORBIMED CAPITAL GP V LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss464284_sc13da.htm SC 13D/A 163093
2 JOINT FILING AGREEMENT ss464284_ex9901.htm EX-99.1 20705
  Complete submission text file 0000947871-15-000841.txt   185511
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Subject) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-88833 | Film No.: 151242126
SIC: 2836 Biological Products, (No Diagnostic Substances)